NAYA Biosciences Inc.

NASDAQ: NAYA · Real-Time Price · USD
2.20
0.17 (8.37%)
At close: Apr 25, 2025, 3:59 PM

NAYA Biosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.53M 3.02M 822.2K 4.16M
Cost of Revenue
3.66M 1.93M 850.77K 145.05K
Gross Profit
2.87M 1.09M -28.57K 4.02M
Operating Income
-8.13M -6.77M -10.63M -5.22M
Interest Income
n/a n/a 308.00 3.66K
Pretax Income
-9.12M -8.01M -10.89M -6.65M
Net Income
-9.1M -8.03M -10.89M -6.65M
Selling & General & Admin
9.08M 7.49M 9.98M 9.02M
Research & Development
489.66K 165.94K 544.04K 216.43K
Other Expenses
1.43M 200.89K 77.3K n/a
Operating Expenses
11M 7.65M 10.6M 9.23M
Interest Expense
1.06M 925.91K 59.45K 1.27M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.66M 9.79M 11.45M 9.38M
Income Tax Expense
-22.91K 27.79K 2.87K 4.76K
Shares Outstanding (Basic)
309.54K 3.13M 2.42M 2.13M
Shares Outstanding (Diluted)
309.54K 3.13M 2.42M 2.13M
EPS (Basic)
-30.19 -5.13 -8.99 -6.26
EPS (Diluted)
-30.19 -5.13 -8.99 -6.26
EBITDA
-7.14M -6.88M -10.75M -5.22M
EBIT
-8.06M -7.08M -10.83M -5.38M
Depreciation & Amortization
919.6K 200.89K 77.3K 166.08K